Exercise as Depression Treatment: Walking, Yoga and Strength Training Show Strong Effects in Major Review

How Effective Is Exercise for Treating Depression?

The BMJ network meta-analysis by Noetel and colleagues pooled data from more than 200 randomised controlled trials involving over 14,000 adults with depression, making it one of the largest syntheses of exercise interventions ever conducted in psychiatry. The authors concluded that walking or jogging, yoga, strength training, and mixed aerobic exercise each yielded moderate effects on depressive symptoms, with benefits that were clinically meaningful rather than merely statistically significant.

Importantly, the analysis found that higher-intensity activity was associated with larger improvements, challenging the common assumption that gentle movement alone is sufficient. The effect sizes observed for several modalities approached those typically reported for cognitive behavioural therapy and selective serotonin reuptake inhibitors, suggesting exercise should be treated as a frontline therapeutic option rather than an adjunct. The authors emphasised, however, that most trials were short in duration and that long-term adherence remains a key clinical challenge.

Which Types of Exercise Work Best for Depression?

Across the pooled evidence, walking and jogging emerged as the most broadly effective intervention, likely because they are accessible, scalable, and tolerable for a wide range of patients. Yoga and strength training also ranked highly, with yoga showing particular benefit in older adults and strength training appearing especially effective in women. Mixed aerobic routines and combined exercise-plus-psychotherapy programmes rounded out the top-performing approaches.

Mechanistically, exercise is thought to reduce depressive symptoms through multiple pathways: increased brain-derived neurotrophic factor (BDNF), reduced systemic inflammation, improved hypothalamic–pituitary–adrenal axis regulation, and enhanced self-efficacy. Clinicians interpreting these findings should note that the evidence supports prescribing exercise with the same specificity applied to medication — recommending a defined modality, frequency, intensity, and duration, rather than vague advice to 'stay active'.

What Do These Findings Mean for Clinical Practice?

Major bodies including the World Health Organization and the UK's National Institute for Health and Care Excellence already recognise physical activity as part of depression management, particularly for mild and moderate presentations. The BMJ analysis adds rigour to that position by quantifying effects across modalities and identifying intensity as a key moderator, providing clinicians with more actionable guidance than generic activity recommendations.

Implementation remains the central challenge. Access to supervised programmes varies widely, insurance coverage is inconsistent, and depressive symptoms themselves — fatigue, anhedonia, low motivation — directly impede adherence. Integrated models that embed exercise referral into primary care, mental health services, and community programmes are likely to be necessary to translate the trial evidence into population-level benefit.